Use of wearable biometric monitoring devices to measure outcomes in randomized clinical trials: a methodological systematic review.

Use of BMDs to measure outcomes is becoming the norm rather than the exception in many fields. Yet, trialists need to account for several methodological issues when specifying and conducting RCTs using these novel tools.